Tumor Immunology Flashcards

1
Q

Cancer accounts for ___% of death in industrialized countries

Current treatments include:

A

20%

Surgery, radiation, chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of carcinogens that induce mutations in DNA

A

Chemical

Radiation

Oncogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Accumulation of mutations that leads to cancer cells (pathway)

A
  1. Lost APC (suppressor gene) = Excessive proliferation
  2. RAS activated (oncogene) = Small benign tumor
  3. DCC lost = Large tumor
  4. p53 lost = Invasive tumor
  5. rapid accumulation of mutations = metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

BRCA1/2 is a type of mutation that results in…

A

Reduced DNA stability or cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lifespan of a typical tumor

A

First visible at 25 doublings (108 cells)

First palpable at ~30 doublings (109 cells)

Death at 1012 cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adenoma cells are more likely to _________

A

remain within a fibrous connective tissue capsule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define

  • Carcinoma
  • Leukemia
  • Lymphoma
  • Myeloma
  • Sarcoma
A

Carcinoma = epithelial cell

Leukemia = circulating cell

Lymphoma = solid tumor in LN

Myeloma = Bone marrow cell

Sarcoma = Connective Tissue cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Some viral proteins induce unchecked proliferation of human cells by blocking ___ and ____

A

P53 and Rb

(tumor suppressor genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Whether or not tumor cells from a person grow in another person depends on _________

A

the MHC haplotype of donors and recipients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tumor cells isolated from primary tumor in a MHC-a mouse effect when injected into:

  1. another MHC-a mouse
  2. A MHC-b mouse
A
  1. Tumors grow, animal dies
  2. Tumor rejected, animal lives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What cells detect tumor cells?

A
  • CD4
  • CD8
  • NK cells
  • B cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T and B cells look for ________, which are differentially expressed by tumor cells and normal cells

A

tumor antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Changes in the genome of tumor cells can lead to __________

A

the expression of tumor antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Difference between tumor specific antigens and tumor associated antigens

A

Whether they are ONLY expressed or just TEND TO BE expressed by tumor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NK cells kill what cells?

A

MHC-I-negative or Ab-coated tumor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 Tumor antigen classes that are recognized by CD8 T cells

(and examples of each)

A

Embryonic = MAGE-1,3

Abnormal PostTransMod’s = MUC-1

Differentiation = Tyrosinase

Mutated oncogene or tumor suppressor = B-catenin, Caspase-8

Oncoviral protein = HPV (E6 and E7 proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Peptide antigens: Disease + Antigens

  • MART2
  • ME1
  • p53
  • KIAA0205
  • Triphosphate isomerase
  • BCR-ABL fusion protein
A
  • MART2 = Melanoma (A1)
  • ME1 = Non-small cell lung carcinoma (A2)
  • p53 = Head/Neck Squamous cell carcinoma (A2)
  • KIAA0205 = Bladder tumor = B44
  • Triphosphate isomerase = Melanoma = DR1
  • BCR-ABL fusion protein = CML = DR4, B8, A2
18
Q

Fusion proteins result in _______

A

New epitopes

19
Q

Two functions of Antibodies to tumor cells

A
  1. facilitate NK cell-mediated lysis of tumor cells
  2. activate complement reaction
20
Q

Two ways that tumor cells activate the CD8 T cell

A

Antigens presented to T cell by APC (with costimulator)

APC activates CD4 helper T cell to release cytokines, which activate CD8

21
Q

Effector phase of anti-tumor CTL response

A

Tumor specific CD8 CTL recognizes tumor cell and kills it

22
Q

Tumor antigens can be presented via _____ which results in activation of…

A

MHC1

Both B cells and T cells

23
Q

6 examples of tumor evasion of immunity

A
  1. out-growth of antigen-negative variants
  2. Loss of MHC proteins
  3. secretion of immunosuppressive cytokines
  4. inducing CTL apoptosis
  5. lack of co-stimulatory signals
  6. soluble tumor antigens (“tolerance)
24
Q

example of an immunosuppressive cytokine produced by tumor cells

Why do these work for tumors?

A

TGF-beta (and TH2 cytokines)

We need the TH1 cell response to fight the cancer

25
What do tumor cells shed to avoid NK cells?
**MHC class I-related chain (MIC)** a ligand of NKG2D (an activating NK cell receptor)
26
Tumors also produce ____ which serves two functions: \_\_\_\_\_ Treg cells \_\_\_\_\_\_ TH1 cells
_TGF-β1_ * Induces Treg cells * Inhibits Th1 cells
27
Treatment for superficial bladder cancer? Why does this work?
**BCG vaccine** (acts as adjuvant for immune response) It works b/c it activates APC's and other cells via **_TLR's_** (also induces _costimulation molecules_ and _MHC molecules_ on APC's)
28
Four promising immunotherapies against tumor cells
1. **Antibody against tumor antigen** (immunotoxins and induction of ADCC by NK cells). 2. **Tumor vaccines**: express B7, GM-CSF or IL-12 in tumor cells. Tumor antigens can be used as vaccines too. e.g. CEA (carcinoembryonic antigen), HSP (heat shock protein), and telomerase 3. **Dendritic cell therapy**: dendritic cells are isolated from patients and are loaded with tumor antigen peptides in vitro. 4. **T cell therapy**: patients T cells, activated in vitro with tumor antigens and cytokines (IL-12), are injected back to the patients.
29
5 Methods used for tumor vaccines
1. Killed tumor cells 2. Purified tumor antigens 3. DC's pulsed with tumor antigens 4. Plasmid DNA immunization 5. DC's transfected with plasmid expressing a tumor antigen
30
therapeutic cancer vaccine for prostate cancer
**Sipuleucel-T** .Patient's blood --\> **DC's** + fusion protein consisting of the antigen **prostatic acid phosphatase** (PAP) and **GM-CSF**
31
Monoclonal antibodies for cancer therapy (4)
**Rituxan** = Anti-CD20 (targets B cells) **Herceptin** = Anti-EFG-receptor-2 (a.k.a. HER2) **Erbitux** = anti-EGFR (HER1) **Avastin** = blocks VEGF receptor
32
Radiolabeled antibodies approved by the FDA to detect cancer (2)
OncoScint, ProstaScint
33
Immunization with MAGE-1/3 induces...
anti-melanoma immune response
34
Rituximab target
CD20
35
Traztuzumab target
HER2
36
Alemtuzumab target
CD52
37
Cetruximab target
EGFR
38
Panitumumab target
EGFR
39
Bevacizumab
VEGF
40
Gemtuzumab target
CD33
41
Ibritumomab and Tositumomab target
CD20
42
Monoclonal antibodies to tumor antigens can deliver \_\_\_\_\_or ____ to tumor cells
Toxins or NK cells